Clinical trials: Immunization Rates
Behavior
DOSE HPV: Development of Systems and Education to Improve HPV Vaccination Rates
After completing over 600 interviews with parents, adolescents, and clinicians to determine reasons why HPV vaccines are used or not used, the investigators recently piloted a communication-based educational intervention with…
- Trial name
- NCT02812732
- Testing
- DOSE HPV
- Volunteers
- 382 people, healthy volunteers welcome
- Sponsor
- Boston Medical Center
Human Papillomavirus
A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates
The purpose of this study is to evaluate the impact of a school-based Human Papillomavirus (HPV) vaccination program to determine if the combination of increased disease and vaccine education coupled with the removal of barriers…
- Trial name
- NCT01526551
- Testing
- HPV Vaccine and HPV-related Health Education, Reduction of barriers
- Where
- 2 sites in United States
- Volunteers
- 935 people, healthy volunteers welcome
- Sponsor
- Lake Cumberland District Health Department
RSV Immunization
An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia
The primary objective of this study is to determine the nirsevimab immunization rate in eligible infants in their first RSV-season in Czechia. The study will focus on: 1.
- Trial name
- NCT07634692
- Testing
- Nirsevimab Respiratory Syncytial Virus monoclonal antibody
- Where
- Czechia
- Volunteers
- 257 people, healthy volunteers welcome
- Sponsor
- Sanofi
Vaccine Compliance
Vaccination Compliance
Retrospective study to assess a single Clinic on Immunization Practices (ACIP) recommendations for hepatitis A, hepatitis B, influenza, tetanus/diphtheria/pertussis, HPV and pneumococcal disease
- Trial name
- NCT03039725
- Testing
- Observational
- Where
- United States
- Volunteers
- 99 people
- Sponsor
- Jaye Shyken, MD
RSV Immunization
RSV Immunisation Status in Queensland (Australia)
The primary objective of this study is to determine the nirsevimab immunisation rate in eligible infants (according to Queensland Paediatric Respiratory Syncytial Virus Prevention Program recommendation) in Queensland, Australia.
- Trial name
- NCT07615192
- Testing
- Nirsevimab Respiratory Syncytial Virus monoclonal antibody
- Where
- Australia
- Volunteers
- 1,113 people, healthy volunteers welcome
- Sponsor
- Sanofi
Human Papilloma Virus, HPV Vaccination
Increasing HPV Vaccination Rates Via Educational Interventions in Schools Located Within Cedars-Sinai Catchment Areas
Infections with human papillomavirus (HPV) can cause cancer of the cervix, vagina, anus, throat, mouth, and penis. Prevention of these HPV-related cancers could be achieved by immunization with the nonavalent…
- Conditions
- Human Papilloma Virus, HPV Vaccination, Health Education
- Trial name
- NCT03953911
- Testing
- Mobile Clinic, Educational Sessions for Parents
- Volunteers
- 3 people, healthy volunteers welcome
- Sponsor
- Cedars-Sinai Medical Center
Childhood Influenza Vaccination, School-located Influenza Vaccination
Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New York
Children in schools in which influenza vaccination clinics are held during school hours will have higher rates of influenza vaccination than children in control schools (no school-located clinics offered)
- Trial name
- SKIPP RCT (NCT02227186)
- Testing
- School-located Influenza Vaccination Clinic
- Where
- United States
- Volunteers
- 20,461 people
- Sponsor
- University of California, Los Angeles
Vaccine Preventable Diseases, Meningococcal Disease
Testing the Use of Prompts to Increase Adolescent Immunization Rates
Although most US adolescents visit their primary care doctor, their immunization rates are low. Primary care practices from two networks, one in upstate New York as well as a national network of pediatric clinics were surveyed to…
- Conditions
- Vaccine Preventable Diseases, Meningococcal Disease, Human Papillomavirus, Pertussis
- Trial name
- AIMHi (NCT01984125)
- Testing
- Point-of-Care Prompt
- Where
- 22 sites in United States
- Volunteers
- 7,040 people
- Sponsor
- University of California, Los Angeles
Influenza, Vaccination
Kaiser Colorado Flu Nudge
Influenza infection leads to significant morbidity and mortality each year. Influenza vaccines can reduce the risk of flu and the severity of flu illness, In addition, flu vaccinations can reduce flu complications such as…
- Trial name
- NCT07372950
- Testing
- Behavioral economics framed test messaging
- Where
- United States
- Volunteers
- 100,000 people
- Sponsor
- Kaiser Permanente
Immunizations, Vaccination
School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities
Purpose of the study. The purpose of the project is to evaluate the feasibility, acceptability, and cost effectiveness of providing influenza vaccine in schools to children in grades Kindergarten through 6th grade.
- Conditions
- Immunizations, Vaccination, Influenza, School Health
- Trial name
- MCSkipp (NCT01224301)
- Testing
- School based flu vaccine: Low intensity, School based flu vaccine: High intensity
- Where
- United States
- Volunteers
- 25,366 people
- Sponsor
- Monroe County Department of Public Health
Reminder Systems, Influenza Vaccines
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado
This study is the second trial related to ClinicalTrials.gov ID: NCT02761551. There are slight changes to methods and a different cohort will be used, thus justifying a 2nd ClinicalTrials.gov submission.
- Trial name
- NCT03246100
- Testing
- Reminders
- Where
- United States
- Volunteers
- 25,531 people
- Sponsor
- University of Colorado, Denver
Influenza
Improving Influenza Vaccination Rates Among Health Care Professionals
The purpose of this study was to see if reminder letters and a large raffle prize would encourage health care workers to receive influenza vaccinations.
- Trial name
- NCT00404664
- Testing
- influenza vaccine, reminders letters, raffle prize
- Where
- United States
- Volunteers
- 800 people, healthy volunteers welcome
- Sponsor
- The Cleveland Clinic
Reminder Systems
HPV IIS Reminder/Recall- New York State
The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve…
- Trial name
- NCT03057379
- Testing
- Vaccine Reminder Recall
- Where
- United States
- Volunteers
- 30,616 people
- Sponsor
- University of California, Los Angeles
Vaccines
HPV Centralized R/R RCT #2 - New York State
The work done in this trial builds off of the work previously conducted by this same research group in clinicaltrials.gov ID: NCT03057379.
- Trial name
- NCT03294551
- Testing
- HPV Vaccine Reminder Recall - Autodialer, HPV Vaccine Reminder Recall - Texting
- Where
- United States
- Volunteers
- 37,003 people
- Sponsor
- University of California, Los Angeles
Pregnancy
Influenza and Text Messaging in Pregnancy
A randomized, controlled clinical trial to assess whether text messaging to an outpatient obstetric population can improve maternal influenza vaccine uptake.
- Trial name
- NCT01248520
- Testing
- influenza and general health information, general health information
- Where
- United States
- Volunteers
- 216 people, healthy volunteers welcome
- Sponsor
- University of Pittsburgh
Vaccine Knowledge, Vaccine Hesitancy
Supporting CHWs as Vaccine Educators: Impact of a Digital Training and Chatbot Intervention on Vaccination in Kenya
This study seeks to understand how to support community health workers (CHWs) to improve routine vaccination rates in high-need areas by testing a two-part intervention.
- Conditions
- Vaccine Knowledge, Vaccine Hesitancy, Vaccine Refusal
- Trial name
- NCT06237374
- Testing
- Digital Vaccine Education Training & Patient-facing Chatbot Tool, Standard Training
- Where
- Kenya
- Volunteers
- 795 people, healthy volunteers welcome
- Sponsor
- Stanford University
Human Papilloma Virus
Virtual Immersive Communication Training on Recommending Immunizations
Our approach will be to implement Virtual Immersive Communication Training on Recommending Immunizations (VICTORI), an intervention that includes a self-directed app based curriculum and VR simulations, designed to increase the…
- Trial name
- NCT04368455
- Testing
- Virtual Immersive Communication Training on Recommending Immunizations (VICTORI), HPV Same Way Same Day App
- Where
- United States
- Volunteers
- 161 people
- Sponsor
- Brittany Rosen
Influenza Viral Infections
Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician
This study is a clinical trial designed to assess the impact on influenza vaccination rates among people aged over 65 of a telephone text message recalling them to be vaccinated by their GP.
- Trial name
- GP-FluRecall (NCT06123936)
- Testing
- Reminder
- Where
- France
- Volunteers
- 8,400 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Covid19
SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers
SCALE-UP Utah is a community-academic partnership to address COVID-19 among Utah community health centers. The long-term objective of the project is to increase the reach, acceptance, and uptake of COVID-19 vaccines among Utah's…
- Trial name
- NCT04939519
- Testing
- Text-Messaging (TM), Patient Navigation (PN)
- Where
- United States
- Volunteers
- 65,300 people, healthy volunteers welcome
- Sponsor
- University of Utah
Healthy
Assessing Choice in the Employer Setting (ACES) Study
The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.
- Trial name
- MA181 (NCT00808808)
- Testing
- Choice of TIV or FluMist with baseline advertisement, Choice of TIV or FluMist with enhanced advertisement and incentives, Control - Usual care offering TIV only with baseline advertisement
- Where
- 47 sites in United States
- Volunteers
- 4,411 people, healthy volunteers welcome
- Sponsor
- MedImmune LLC